Evidence map›Paper›PMID 22026501›Full record

ArticleAddiction biology2014

Ventral midbrain correlation between genetic variation and expression of the dopamine transporter gene in cocaine-abusing versus non-abusing subjects.

Yanhong Zhou, Sharon K Michelhaugh, Carl J Schmidt, Jun S Liu, Michael J Bannon, Zhicheng Lin

Open access · greenAbstract read
In one paragraph

Article in Addiction biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
0.8field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Synaptic ZnTranslational psychiatry · 2021
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Molecular neurobiology · 2018
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. A molecular profile of cocaine abuse includes the differential expression of genes that regulate transcription, chromatin, and dopamine cell phenotype.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2014
    Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Yanhong ZhouDepartment of Psychiatry, Harvard Medical School and Division of Alcohol and Drug Abuse, McLean Hospital, Belmont, MA, USA Department of Pharmacology, Wayne State University School of Medicine, Detroit, MI, USA Department of Pathology, Wayne State University School of Medicine, Detroit, MI, USA Department of Statistics, Harvard University, Cambridge, MA, USA.
Sharon K Michelhaugh
Carl J Schmidt
Jun S Liu
Michael J Bannon
Zhicheng Lin
Wayne State University · USHarvard University · USMcLean Hospital · US

Funding

Human dopamine transporter gene: variations and transcriptional regulationR01DA021409 · NIDA · MCLEAN HOSPITAL · PI LIN, ZHICHENG CARL · 2007 to 2024
$4.9M
COCAINE-BINDING DOPAMINE TRANSPORTER: MOLECULAR BIOLOGYR01DA006470 · NIDA · WAYNE STATE UNIVERSITY · PI BANNON, MICHAEL J · 1990 to 2016
$4.4M
NIDA NIH HHS R01 DA006470NIDA NIH HHS R01DA006470NIDA NIH HHS R01 DA021409NIDA NIH HHS R01DA021409
6 · The paper itself

Abstract

Altered activity of the human dopamine transporter gene (hDAT) is associated with several common and severe brain disorders, including cocaine abuse. However, there is little a priori information on whether such alterations are due to nature (genetic variation) or nurture (human behaviors such as cocaine abuse). This study investigated the correlation between seven markers throughout hDAT and its mRNA levels in postmortem ventral midbrain tissues from 18 cocaine abusers and 18 strictly matched drug-free controls in the African-American population. Here, we show that one major haplotype with the same frequency in cocaine abusers versus drug-free controls displays a 37.1% reduction of expression levels in cocaine abusers compared with matched controls (P=0.0057). The most studied genetic marker, variable number tandem repeats (VNTR) located in Exon 15 (3'VNTR), is not correlated with hDAT mRNA levels. A 5' upstream VNTR (rs70957367) has repeat numbers that are positively correlated with expression levels in controls (r(2)=0.9536, P=0.0235), but this positive correlation disappears in cocaine abusers. The findings suggest that varying hDAT activity is attributable to both genetics and cocaine abuse.

Indexed as

AdultAgedAllelesAnalysis of VarianceBlack or African AmericanCase-Control StudiesCocaine-Related DisordersDopamine Plasma Membrane Transport ProteinsEpigenesis, GeneticExonsFemaleGene ExpressionGene Expression RegulationGenetic MarkersGenetic Predisposition to DiseaseGenetic VariationDopamine Plasma Membrane Transport ProteinsGenetic MarkersRNA, MessengerAddictionDATepigeneticsexpressional variationpharmacogenomicspostmortem

Identifiers

PMID22026501
PMCPMC3270208
OpenAlexW1669099788

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.